$7.36
0.030.41%
Last update: Nov 9, 4:00 PM
Olema Pharmaceuticals inc
OLMANASDAQ
Olema Pharmaceuticals fell 15.4% from $8.70 to $7.36, behind the S&P 500's +10.5%. Its worst day was Mar 9 (−25.8%), and its low came Oct 23 at $6.41.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.49 missed the $-0.44 estimate on $0.00 revenue.
0.0% · S&P 500 +1.6%
Olema Pharmaceuticals shares rose 136.4%, while the S&P 500 fell 0.8%.
+136.4%, the year's best day, on 87M shares, the year's heaviest volume · S&P 500 −0.8%
Olema Pharmaceuticals closed at its highest level of the year, 311.8% above where the year started.
+8.4% · S&P 500 −0.2%
EPS of $-0.50 beat the $-0.52 estimate on $0.00 revenue.
+12.8% · S&P 500 +1.0%
EPS of $-0.52 beat the $-0.54 estimate on $0.00 revenue.
−6.0% · S&P 500 −0.2%
EPS of $-0.61 missed the $-0.56 estimate on $0.00 revenue.
−12.6% · S&P 500 −0.3%
Olema Pharmaceuticals closed at its lowest level of the year, 26.3% below where the year started.
−8.7% · S&P 500 −0.5%
Where it ended: a close of $7.36 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 10, 2026 (EPS est. $-0.63, revenue est. $2.0M).
Nothing in the past 12 months.
All OLMA dividend history
